Changes in Stage at Presentation among Lung and Breast Cancer Patients During the COVID-19 Pandemic
Authors
Mallouh, MichaelLinshaw, David
Barton, Bruce
De La Cruz, Gabriel
Dinh, Kate
LaFemina, Jennifer
Vijayaraghavan, Gopal
Larkin, Anne
Whalen, Giles
UMass Chan Affiliations
Population and Quantitative Health SciencesRadiology
Surgery
T.H. Chan School of Medicine
Document Type
Journal ArticlePublication Date
2023-02-17
Metadata
Show full item recordAbstract
Background: The COVID-19 pandemic altered access to healthcare by decreasing number of patients able to receive preventative care and cancer screening. We hypothesized that given these changes in access to care, radiologic screening for breast and lung cancer would be decreased, and patients with these cancers would consequently present at later stages of their disease. Design: Retrospective cross-sectional study of 2017-September 2021 UMass Memorial Tumor Registry for adult breast and lung cancer patients. Changes in stage at presentation of breast and lung cancer during the COVID-19 pandemic were measured, defined as prior to and during COVID-19. Results: There were no statistically significant changes in the overall stage of presentation before or during the COVID-19 pandemic for either breast or lung cancer patients. Analysis of case presentation and stage during periods of COVID-19 surges that occurred over the time of this study compared to pre-pandemic data demonstrated a statistically significant decrease in overall presentation of breast cancer patients in the first surge, with no other statistically significant changes in breast cancer presentation. A non-statistically significant decrease in lung cancer presentations was seen during the initial surge of COVID-19. There was also a statistically significant increase in early-stage presentation of lung cancer during the second and third COVID-19 surges. Conclusions: In the two years after the COVID-19 pandemic we were not able to demonstrate stage migration at presentation of breast and lung cancer patients to later stages despite decreases in overall presentation during the initial two years of the COVID pandemic. An increase in early-stage lung cancer during the second and third surges is interesting and could be related to increased chest imaging for COVID pneumonia.Source
Mallouh M, Linshaw D, Barton B, De La Cruz G, Dinh K, LaFemina J, Vijayaraghavan G, Larkin A, Whalen G. Changes in Stage at Presentation among Lung and Breast Cancer Patients During the COVID-19 Pandemic. J Am Coll Surg. 2023 Feb 17:e000656. doi: 10.1097/XCS.0000000000000656. Epub ahead of print. PMID: 36799501.DOI
10.1097/XCS.0000000000000656Permanent Link to this Item
http://hdl.handle.net/20.500.14038/51765PubMed ID
36799501Rights
Copyright © 2023 by the American College of Surgeons. Published by Wolters Kluwer Health, Inc. All rights reserved.ae974a485f413a2113503eed53cd6c53
10.1097/XCS.0000000000000656